ENHANCED PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA (TFN-ALPHA) BY ITS PRECURSOR ON THE CELL-SURFACE OF PRIMED THP-1 CELLS

被引:18
作者
TANABE, Y [1 ]
KITAHARATANABE, N [1 ]
MIZUNO, D [1 ]
SOMA, GI [1 ]
机构
[1] TEIKYO UNIV,BIOTECHNOL RES CTR,MIYAMAE KU,KAWASAKI,KANAGAWA 216,JAPAN
关键词
MACROPHAGE; PRIMED STAGE; TNF; TNF PRECURSOR; TRIGGERED STAGE;
D O I
10.1016/1043-4666(94)90056-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To clarify the biological significance of tumour necrosis factor α (TNF-α) precursor, we analysed its expression at the primed and triggered stages using human monocyte-like cell line THP-1. To prime them, THP-1 cells were treated with either recombinant human interferon γ (rIFN-γ) or recombinant human tumour necrosis factor α (rTNF-α). At the primed stage, transient accumulation of TNF-α, mRNA and a small amount of 26-KDa TNF-α precursor were observed, and the precursor molecule was located on the cell surface. Following treatment of the primed cells with bacterial lipopolysaccharide (LPS), augmentation of transcription of TNF-α mRNA and production of a larger amount of TNF-α precursor were observed followed by secretion of a larger amount of mature TNF-α (17-KDa) than secreted by the unprimed cells (triggered stage). This suggests that with priming THP-1 cells might be changed to a stage where they are ready for production of a larger amount of TNF-α at the triggered stage. When either primed or unprimed THP-1 cells were pretreated with anti-TNF-α antibody, augmentation of TNF-α production by primed THP-1 cells was specifically suppressed, suggesting that TNF-α precursor itself may play an important role in the enhancement of TNF-α production by the primed macrophages after treatment with LPS. © 1994.
引用
收藏
页码:337 / 348
页数:12
相关论文
共 52 条
  • [1] ASHER AL, 1991, J IMMUNOL, V146, P3227
  • [2] SOLUBLE TNF AND MEMBRANE TNF EXPRESSED ON CD4+T LYMPHOCYTES DIFFER IN THEIR ABILITY TO ACTIVATE MACROPHAGE ANTILEISHMANIAL DEFENSE
    BIRKLAND, TP
    SYPEK, JP
    WYLER, DJ
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 51 (03) : 296 - 299
  • [3] TUMOR SUPPRESSION AFTER TUMOR-CELL TARGETED TUMOR-NECROSIS-FACTOR-ALPHA GENE-TRANSFER
    BLANKENSTEIN, T
    QIN, ZH
    UBERLA, K
    MULLER, W
    ROSEN, H
    VOLK, HD
    DIAMANTSTEIN, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) : 1047 - 1052
  • [4] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [5] BURCHETT SK, 1988, J IMMUNOL, V140, P3473
  • [6] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [7] NUMBER AND EVOLUTIONARY CONSERVATION OF ALPHA-TUBULIN AND BETA-TUBULIN AND CYTOPLASMIC BETA-ACTIN AND GAMMA-ACTIN GENES USING SPECIFIC CLONED CDNA PROBES
    CLEVELAND, DW
    LOPATA, MA
    MACDONALD, RJ
    COWAN, NJ
    RUTTER, WJ
    KIRSCHNER, MW
    [J]. CELL, 1980, 20 (01) : 95 - 105
  • [8] GAMMA-INTERFERON ENHANCES MACROPHAGE TRANSCRIPTION OF THE TUMOR-NECROSIS-FACTOR CACHECTIN, INTERLEUKIN-1, AND UROKINASE GENES, WHICH ARE CONTROLLED BY SHORT-LIVED REPRESSORS
    COLLART, MA
    BELIN, D
    VASSALLI, JD
    DEKOSSODO, S
    VASSALLI, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (06) : 2113 - 2118
  • [9] COLLINS SJ, 1987, BLOOD, V70, P1233
  • [10] FIRESTONE GL, 1990, METHOD ENZYMOL, V182, P688